WEGOVY 2.4MG/DOSE PREFILLED PEN – CANADIAN PHARMACEUTICAL GRADE SEMAGLUTIDE INJECTION

Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.

This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.

The Details:

Dosage: 2.4mg semaglutide per dose
Form: Prefilled injection pen
Quantity: Single-use pen, ready for controlled application
Packaging: Sterile, tamper-evident pen in sealed packaging
Source: Canadian pharmaceutical grade

Key Features of Wegovy 2.4mg:

Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.
GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.
Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.
Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.
Pharmaceutical Authenticity: Canadian-produced and independently verified.